Johnson Johnson Profile

USD 0.09  0.07%

Johnson Johnson exotic insider transaction detected

Johnson Johnson insider trading alert for general transaction of common by Langbo Arnold G, the corporate stakeholder, on July 22, 2018. This event was filed by Johnson Johnson with SEC on 2008-12-11. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Johnson Johnson Summary

Johnson & Johnson are known for their many different products. Odds are if you search your bathroom you will find multiple products made by this company. Solid and sound, the company has been upgraded by Wells Fargo, which is positive news for price movement. As well as that, the company has acquired the company Actelion, which operates in the biotech industry. [more]
Johnson Johnson (JNJ) is traded on BATS Exchange in USA. It is located in NEW JERSEY U.S.A and employs 134,000 people. Johnson Johnson is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 337.55 B. Johnson Johnson runs under Healthcare sector within Healthcare Products industry. This company has 2.68 B outstanding shares of which 18.77 M shares are currently shorted by investors with about 2.91 days to cover shorted positions. JOHNSON AND JOHNS has about 15.2 B in cash with 16.97 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.67.
Check Johnson Johnson Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 125.85HorizonTargetOdds Above 125.85
70.94%30 days 125.85 28.59%
Based on normal probability distribution, the odds of Johnson Johnson to move above current price in 30 days from now is about 28.59% (This Johnson Johnson probability density function shows the probability of Johnson Johnson Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Fisher Asset Management LlcCommon Shares13.1 M1.6 B
Bank Of MontrealCommon Shares6.9 M838.5 M
View Johnson Johnson Diagnostics

Selected Johnson Johnson Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Johnson Johnson Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Johnson Johnson are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Johnson Johnson was founded in 1885 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug Manufacturers - Major classification in USA and traded on BATS Exchange. It employs 134000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Johnson Johnson SEC Filings
Johnson Johnson SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameJohnson Johnson
ChairmanAlex GorskyView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 6 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
RegionNorth America
Business AddressOne Johnson & Johnson Plaza
Foreign Associates
ExchangeBATS Exchange
CIK Number0000200406
IndustryHealthcare Products
Phone732 524 0400
CurrencyUSD - US Dollar

Johnson Johnson Corporate Directors

William Perez Independent Director
Mary Coleman Independent Director
Mary Beckerle Director
Please also check Risk vs Return Analysis. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.